Corticosteroids for community-acquired pneumonia: a critical view of the evidence.

There has been little progress in the management of CAP since the widespread introduction of antibiotics in the 1950s, with no new classes of drugs licensed specifically for CAP and little progress in reducing mortality. The focus of international guidelines for CAP have been on “doing the simple things well”, since early antibiotic administration, appropriate fluid resuscitation, early mobilisation and guideline-concordant antibiotics have been associated with improved outcomes, albeit with low-quality evidence [3–5].